Coral Laboratories Ltd. engages in the manufacture of pharmaceutical formulations. The company is headquartered in Mumbai, Maharashtra and currently employs 109 full-time employees. The firm is engaged in the manufacturing of pharmaceutical formulations. The firm operates through Formulations segment. Its product portfolio includes non-sterile, sterile, nutraceutical and OTC + lifestyle. The firm's dosage forms include tablets, capsules, ointment and creams, liquid orals, b-lactam, topical preparations, eye/ear drops, nasal sprays, dry syrup, gels and lotions, injections (liquids and powder), granules powder, dry syrup, suppositories, and B-lactam among others. The company offers its products in various therapeutic areas, including antibiotics/antibacterial, anti-fungal, gastro-intestinal drugs, anti-emetics, analgesic/antipyretic/anti-inflammatory, antispasmodic, muscle relaxants, antiprotozoal/antiamoebic, anti-cold, herbal medicine, topical preparations, appetizer, oral antiseptic preparations, antimalarial drugs, cough suppressant/expectorant and mouthwash.
Loading chart…
Our models read the latest earnings call, annual report, and financials end-to-end - then grade management, value the business, and flag the risks. Unlock all of it for this company:
The headline call - descriptive label, conviction, and the synthesis behind it.
Guidance-anchored P&L bridge - worst / average / best multiple cases.
Did management deliver on past guidance? A commitment-by-commitment scorecard.
Forensic and governance risk pointers, severity-ranked.
Solvency and earnings-quality score.
Quarter-by-quarter earnings-call briefs - what changed and why.